Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 12

From Current Patent Gazette

April 1, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

RemeGen discloses new anti-c-Met antibody-drug conjugates

April 1, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Galderma discovers JAK-1 inhibitors

April 1, 2022

Medshine Discovery divulges thyroid hormone receptor beta agonists

April 1, 2022

New NLRP3 inflammasome inhibitors identified at NodThera

March 31, 2022

New STAT5 inhibitors synthesized at Janpix

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...